Wu-Mei-Wan Reduces Insulin Resistance via Inhibition of NLRP3 Inflammasome Activation in HepG2 Cells

Figure 1

Effects of 0.25 mM palmitate (PA) on glucose consumption rate of HepG2 cells at different treatment times. Control group is HepG2 cells in the normal state without PA treatment, whereas PA 12 h, PA 24 h, and PA 48 h groups are HepG2 cells treated with 0.25 mM palmitate for 12, 24, and 48 h, respectively. Compared to the control group, the glucose consumption rate in palmitate-treated HepG2 cells for 12, 24, and 48 h was 81.3, 63, and 62.3%, respectively. ; .